The people with diabetes and rheumatoid arthritis are more likely to suffer from patellar tendinitis. The patient population suffering from diabetes and rheumatoid arthritis is increasing continuously, which significantly increased the demand for the treatment of the tendinitis drugs. Additionally, adoption of the sedentary lifestyle has fuelled the market growth.
Over the last decade, the total number of hospitals has increased to a great extent, which has influenced the growth of the market positively. Moreover, increasing demand for better treatment and changing reimbursement policies have fueled the market growth.
Request For Sample Report: https://www.marketresearchfuture.com/sample_request/5134
The Americas patellar tendinitis market is expected to show an extensive growth owing to increasing number of sports injuries, availability of cost-effective treatment, and flourishing growth of the sports medicine. Furthermore, technological advancement in the health care also accelerates the market growth.
Europe holds the second largest share of the global market. As per the European Union Injury Database, home, leisure, and sports injuries accounted for 73% of all injuries treated every year. It is also stated that sports injuries were common among the population from 10 to 19 years of age. Furthermore, over 7.9 million children under the age of 15 are treated for an injury in European Union (EU) hospitals each year. Out of the total sports injuries, team ball sports account for 40% of all hospital-treated injuries, and the prevalence of sports injuries was found to be higher among men than women. Additionally, In the EU, muscle strains, tendonitis, and stress fracture are the common chronic sports injuries. As per the article published in the Clinics in the Orthopedic Surgery, traumatic tendon injuries are commonly treated sports injuries, especially in the emergency department of the hospital. Additionally, soccer, tennis, indoor ball games, and downhill skiing are various games resulting in Achilles tendon ruptures.
The Asia Pacific is the fastest growing patellar tendinitis market across the globe. Japan holds a major share of the regional market due to the availability of technology and huge healthcare spending. Rapidly developing the economy, increasing healthcare expenditure, and government initiatives for research & development will drive the market in China and India over the assessment period.
The Middle East and Africa hold the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market whereas, the African region is expected to witness a moderate growth.
Browse Full Report @ https://www.marketresearchfuture.com/reports/patellar-tendinitis-market-5134 .
The global patellar tendinitis market is segmented on the basis of diagnosis, treatment, and end user. On the basis of diagnosis, it is segmented into the physical examination, imaging tests, and others. An imaging test is further segmented into X-rays, Ultrasound, and Magnetic resonance imaging (MRI). The treatment segment is divided into corticosteroid injection, platelet-rich plasma injection, surgery, Medical devices, and others. Medical devices are further segmented into the mechanical band, support tape, pre-cut strips, continuous rolls, and others. Based on the end user, it is segmented into hospitals & clinics, research laboratories, and others.
Some of key the players in the market are Toshiba Medical Systems Corporation (Japan), Carestream Health (U.S.), Nihon Kohden Corporation (Japan), Electrical Geodesics Inc. (U.S.), Fujifilm Holdings (Japan), GE Healthcare (U.S.), Siemens Healthcare(U.S.), Philips Healthcare (U.S.), Shimadzu Corporation (Japan), Masimo Corporation (U.S.), Hologic (U.S.), Esaote (Italy), and others.